Get started
Author

Saray Rodríguez-Diaz

Observed names: S. Rodríguez, Saray Rodriguez, Saray Rodriguez-Diaz, Saray Rodríguez, Saray Rodríguez-Díaz
ORCID: 0000-0001-6799-8002
Observed ORCID: 0000-0001-6799-8002
OpenAlex ID: A5000289836
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
2022 · Paula Rodriguez-Marquez, Maria E. Calleja-Cervantes, et al. · Science Advances · 115
PDF
CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I
2018 · Nerea Zabaleta, Miren Barberia, et al. · Nature Communications · 89
PDF
Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in multiple myeloma
2024 · Maria Luisa Palacios-Berraquero, Paula Rodriguez-Marquez, et al. · Blood Advances · 30
Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia
2023 · Cristina Calviño, Candela Ceballos, et al. · Frontiers in Immunology · 28
In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria
2022 · Rebeca Martinez-Turrillas, Angel Martin-Mallo, et al. · Molecular Therapy — Methods & Clinical Development · 25
PDF
Cardiotrophin 1 protects beta cells from apoptosis and prevents streptozotocin-induced diabetes in a mouse model
2013 · M. Jiménez-González, F. Jaques, et al. · Diabetologia · 20
PDF
Generation and characterization of human iPSC lines derived from a Primary Hyperoxaluria Type I patient with p.I244T mutation
2015 · Natalia Zapata-Linares, Saray Rodriguez, et al. · Stem Cell Research · 18
PDF
CAR Density Influences Antitumoral Efficacy of BCMA CAR-T Cells and Correlates with Clinical Outcome
2021 · Paula Rodriguez-Marquez, Maria Erendira Calleja-Cervantes, et al. · Blood · 16
Generation and characterization of human iPSC line generated from mesenchymal stem cells derived from adipose tissue
2015 · Natalia Zapata-Linares, Saray Rodriguez, et al. · Stem Cell Research · 16
PDF
Generation and GMP scale-up of human CAR-T cells using non-viral Sleeping Beauty transposons for B cell malignances
2025 · Begoña Diez, Cristina Calviño, et al. · Molecular Therapy — Methods & Clinical Development · 15
Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome
2017 · Juan Roberto Rodriguez-Madoz, Edurne San Jose-Eneriz, et al. · PLoS ONE · 15
PDF
Cardiac Progenitor Cell Exosomal miR-935 Protects against Oxidative Stress
2023 · Susana Aguilar, Paula García-Olloqui, et al. · Cells · 13
PDF
Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML
2025 · Franco Bernasconi-Bisio, Eva Molina, et al. · Molecular Therapy Oncology · 9
Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy
2021 · Ascensión López-Díaz de Cerio, Iñigo Perez-Estenaga, et al. · Pharmaceutics · 9
PDF
Pancreatic differentiation of Pdx1-GFP reporter mouse induced pluripotent stem cells
2016 · Angelo Porciuncula, Anujith Kumar, et al. · Differentiation · 8
PDF
Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma
2026 · Lorea Jordana-Urriza, Guillermo Serrano, et al. · Blood Neoplasia · 6
Generation of an induced pluripotent stem cell line (CIMAi001-A) from a compound heterozygous Primary Hyperoxaluria Type I (PH1) patient carrying p.G170R and p.R122* mutations in the AGXT gene.
2019 · Rebeca Martinez-Turrillas, Saray Rodriguez-Diaz, et al. · Stem Cell Research · 4
PDF
Lessons from 11C-dihydrotetrabenazine imaging in a xenograft mouse model of rat insulinoma: is PET imaging of pancreatic beta cell mass feasible?
2017 · María Collantes, Miguel Barajas, et al. · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · 3
BCMA CAR-T Cell Phenotype and Functionality Is Affected By Disease Stage of Multiple Myeloma Patients
2022 · Angel Martin-Mallo, Maria Erendira Calleja-Cervantes, et al. · Blood · 1
Rational engineering of sdAb-based CAR T cells targeting BCMA enhances antitumor efficacy and persistence in Multiple Myeloma
2026 · Vianca Ibarra-García, Maria E. Calleja-Cervantes, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Rapid and dynamic reprogramming within the tumor microenvironment drives EDA-CAR-T dysfunction and compromised therapeutic efficacy in solid tumors
2026 · Rodrigo Redondo-Frutos, Pedro Justicia-Lirio, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Improving CRISPR-Cas9 Screens in CAR T Cells: A Refined Method for Library Preparation
2026 · Maider Garnica, Patxi San Martin-Uriz, et al. · Journal of Visualized Experiments
Innovative sdab-based CAR-T cells targeting BCMA outperform current CAR-T therapies for multiple myeloma
2025 · Vianca Ibarra-Garcia, Maria Erendira Calleja-Cervantes, et al. · Blood
P-073 Identification and Validation of Factors Promoting Resistance to CAR-T Therapy in Multiple Myeloma by Genome-Wide CRISPR Screenings
2024 · Paula Rodriguez-Marquez, Yimei Que, et al. · Clinical Lymphoma Myeloma & Leukemia
271 Development and characterisation of humanised scFv CAR-T therapies targeting BCMA against multiple myeloma
2023 · Jorge Illarramendi, Rebeca Martinez-Turrillas, et al. · Journal for ImmunoTherapy of Cancer
PDF
Works count: 27
Citation count: 440
H-index: 12
I10-index: 12
Year
Topic
Type